Ibrutinib induces multiple functional defects in the neutrophil response against Aspergillus fumigatus

The Bruton tyrosine kinase inhibitor ibrutinib has become a leading therapy against chronic lymphoid leukemia. Recently, ibrutinib has been associated with the occurrence of invasive fungal infections, in particular invasive aspergillosis. The mechanisms underlying the increased susceptibility to fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Blez, Damien, Blaize, Marion, Soussain, Carole, Boissonnas, Alexandre, Meghraoui-Kheddar, Aïda, Menezes, Natacha, Portalier, Anaïs, Combadière, Christophe, Leblond, Véronique, Ghez, David, Fekkar, Arnaud
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012467/
https://www.ncbi.nlm.nih.gov/pubmed/31171644
http://dx.doi.org/10.3324/haematol.2019.219220

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012467/
https://www.ncbi.nlm.nih.gov/pubmed/31171644
http://dx.doi.org/10.3324/haematol.2019.219220

Ejemplares similares